November 25th, 2011 by KerriSparling in True Stories
No Comments »
It’s that well-worn tale of Pavlov and his crazy dogs, the ones that he trained to expect treats whenever a bell was rung. And whether or not the treats were offered, the dogs learned to respond by salivating, waiting.
Diabetes has made me one of Pavlov’s dogs. But instead of the chimes of a bell triggering salivation, it’s the sound of the Top Gun theme song coming from my insulin pump, making me check the status of my battery. Or the sound of my Dexcom letting loose with a BEEEEEEEP!, making me reach for my glucose meter. The sounds of diabetes are so ingrained in my brain that I don’t think before responding. My reaction to certain sounds is visceral.
Sometimes the sounds of my diabetes are subtle – Read more »
*This blog post was originally published at Six Until Me.*
November 16th, 2011 by PJSkerrett in Health Tips
No Comments »
[Editor's note: In recognition of American Diabetes Month, Harvard Health Publications is collaborating with MSN.com on its Stop Diabetes initiative. Today's post, published on World Diabetes Day, is the first of several focusing on this all-too-common disorder.]
People tend to think of diabetes as a silent, painless condition. Don’t tell that to the millions of folks with diabetes-induced tingling toes or painful feet. This problem, called diabetic neuropathy, can range from merely aggravating to disabling or even life threatening. It’s something I have first-hand (or, more appropriately, first-foot) knowledge about.
High blood sugar, the hallmark of diabetes, injures nerves and blood vessels throughout the body. The first nerves to be affected tend to be the smallest ones furthest from the spinal cord—those that stretch to the toes and feet.
Diabetic neuropathy affects different people in different ways. I feel it as Read more »
*This blog post was originally published at Harvard Health Blog*
November 10th, 2011 by KerriSparling in Opinion
No Comments »
Last week (was it only a week ago? My time-space continuum is completely off kilter these days), I was out in San Francisco for a quick visit at the Lifescan Town Hall meeting.
Okay, I was actually in Milpitas, which is a nice little place that the driver from the airport inadvertently described as, “Why are you going there?” Not exactly the same excitement as the home of the Golden Gate Bridge and other sights I saw from the car, but close.
I was asked to come out and talk about life with diabetes to a large group of Lifescan employees (they make the One Touch meters and they clearly like people who play guitar because Crystal Bowersox and B.B. King are their buddies, so I felt a little musically inept). I wasn’t asked to talk about my meter, or my pump, or to pimp out any partnerships, etc. They just wanted to hear about life with diabetes. Plain life. Real life.
Because I don’t have a formal bone in my body (all of my bones are in sweatpants and baseball caps), and because I didn’t have any airs to put on, I just stood on that stage showed them our community. I showed them some of our blogs, and talked about some of our meet-ups. I showed them that while life with diabetes can be challenging, Read more »
*This blog post was originally published at Six Until Me.*
November 4th, 2011 by KerriSparling in True Stories
No Comments »
A few weeks ago, I posted a photo and part of an email from a reader who had made an insulin pump-shaped cake for their daughter’s birthday. In that magical way of the Internet (where cats haz a cheeseburger and lovely little bean people talk about diabetes), another family with a kid pumping insulin caught the post, and baked up a little bolus of their own.
So, to kick off Diabetes Month here, I connected with Gwyneth’s mom, and Gwyneth emailed me her perspective on what it’s like to mark her first diaversary, which is TODAY. At the start of Diabetes Month. How’s that for timing? Read more »
*This blog post was originally published at Six Until Me.*
November 3rd, 2011 by Medgadget in Research
No Comments »
Medtronic received the go-ahead to begin an at-home U.S. trial of its Low Glucose Suspend technology that aims to prevent hypoglycemia by automatically stopping basal insulin delivery when measured glucose reaches a critically low level.
The pump technology is already available in Europe on the company’s Paradigm Veo insulin pump.
This is the second phase of the ASPIRE (Automation to Simulate Pancreatic Insulin REsponse) study, following the completion of the in-patient clinical study. ASPIRE is a multi-center, randomized, pivotal in-home study being conducted at multiple investigational centers to determine the safety and efficacy of the Low Glucose Suspend feature in the sensor-augmented MiniMed Paradigm insulin pump. Medtronic’s newest continuous glucose sensor, the Enlite™ sensor, will be tested as part of the overall system.
ASPIRE will compare Read more »
*This blog post was originally published at Medgadget*
